Literature DB >> 3880760

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

J D Vassalli, D Baccino, D Belin.   

Abstract

The secretion of plasminogen activators has been implicated in the controlled extracellular proteolysis that accompanies cell migration and tissue remodeling. We found that the human plasminogen activator urokinase (Uk) (Mr 55,000 form) binds rapidly, specifically, and with high affinity to fresh human blood monocytes and to cells of the monocyte line U937. Upon binding Mr 55,000 Uk was observed to confer high plasminogen activator activity to the cells. Binding of the enzyme did not require a functional catalytic site (located on the B chain of the protein) but did require the noncatalytic A chain of Mr 55,000 Uk, since Mr 33,000 Uk did not bind. These results demonstrate the presence of a membrane receptor for Uk on monocytes and show a hitherto unknown function for the A chain of Uk: binding of secreted enzyme to its receptor results in Uk acting as a membrane protease. This localizes plasminogen activation near the cell surface, an optimal site to facilitate cell migration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880760      PMCID: PMC2113459          DOI: 10.1083/jcb.100.1.86

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  35 in total

1.  Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins.

Authors:  H Hjelm; K Hjelm; J Sjöquist
Journal:  FEBS Lett       Date:  1972-11-15       Impact factor: 4.124

2.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

5.  Isolation and characterization of urokinase from human plasma.

Authors:  T C Wun; W D Schleuning; E Reich
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

6.  Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.

Authors:  G Markus; H Takita; S M Camiolo; J G Corasanti; J L Evers; G H Hobika
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

7.  Structural relationship between human high and low molecular mass urokinase.

Authors:  W A Günzler; G J Steffens; F Otting; G Buse; L Flohé
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-02

8.  Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.

Authors:  O Matsuo; D C Rijken; D Collen
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

9.  Chemotactic response of monocytes to thrombin.

Authors:  R Bar-Shavit; A Kahn; J W Fenton; G D Wilner
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

10.  Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

Authors:  J D Vassalli; J M Dayer; A Wohlwend; D Belin
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  157 in total

1.  Isolation and characterization of cell lines with reduced urokinase binding.

Authors:  H K Lau; J M Teitel; M Kim
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 3.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

4.  Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors:  Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2008-10-15       Impact factor: 2.860

5.  BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.

Authors:  Yosuke Morodomi; Tokujiro Yano; Hiroaki Kinoh; Yui Harada; Satoru Saito; Ryoichi Kyuragi; Kumi Yoshida; Mitsuho Onimaru; Fumihiro Shoji; Tsukihisa Yoshida; Kensaku Ito; Yasunori Shikada; Riichiroh Maruyama; Mamoru Hasegawa; Yoshihiko Maehara; Yoshikazu Yonemitsu
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

6.  Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Authors:  D A Waltz; L R Natkin; R M Fujita; Y Wei; H A Chapman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 7.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

8.  Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.

Authors:  L R Lund; V Ellis; E Rønne; C Pyke; K Danø
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines.

Authors:  A R Nusrat; H A Chapman
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.

Authors:  K Yamamoto; D J Loskutoff
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.